DC Field | Value | Language |
dc.contributor.author | Khaled, Bwirat | - |
dc.date.accessioned | 2020-10-15T08:08:06Z | - |
dc.date.available | 2020-10-15T08:08:06Z | - |
dc.date.issued | 2020 | - |
dc.identifier.citation | KHALED, Bwirat. Sleep disturbances in Parkinson `s disease. In: MedEspera: the 8th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2020, p. 134. | en_US |
dc.identifier.uri | https://medespera.asr.md/wp-content/uploads/ABSTRACT-BOOK.pdf | - |
dc.identifier.uri | http://repository.usmf.md/handle/20.500.12710/12178 | - |
dc.description | Department of Neurology,
Nicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, Republic of
Moldova, The 8th International Medical Congress for Students and Young Doctors, September 24-26, 2020 | en_US |
dc.description.abstract | Introduction. Sleep disorders are among one of the earliest and most common non-motor
symptoms of Parkinson's disease (PD). The nature of sleep is considered to be the major cause
of lack of satisfaction of life quality in patients with Parkinson’s disease. Despite well-known
sleep disorders in PD, sleep has been a rare and mostly neglected topic in PD research. The
prevalence of sleep disturbances in patients with PD, range from 65% up to 95%, which point
that sleep disorders in PD patients are not rare and require increased awareness from clinician
and researchers.
Aim of the study. Evaluation of sleep disorders in PD patients and the influence of PD stage,
medications, pain, anxiety and depression on PD patients sleep quality.
Materials and methods. Forty PD patients were included in the study. Clinical demographic
data were recorded. Disease stage was evaluated by the Hoehn and Yahr rating scale, sleep
quality by Pittsburgh Sleep Quality Index (PSQI), sleep disturbances by the Parkinson’s disease
sleep scale (PDSS-2 scale), excessive daytime sleepiness was identified by the Epworth
Sleepiness Scale (ESS).And depressive and anxiety symptoms by the Hospital Anxiety and
Depression Scale (HADS). Control group of forty participants age healthy matched also
completed the PDSS-2 scale.
Results. 70% of the patients have PSQI score more than 5 which indicate poor sleep quality.
The result show that PD patients with reported pain have mean PSQI score 9.52 in comparison
to PD patients without pain with a mean score 8.24. The mean PSQI score for those who got
HADS anxiety subscale more than 10 was 8.79 where those who got less than 10 have a mean
PSQI mean score 8.89. For patients who got in HADS depression subscale a score more than
10, the mean PSQI score was 9.94 and for those who got a score less than 10 have PSQI score
8.464. The mean PDSS-2 score for PD patients was 95.43 ± 14.57 and for matched age healthy
control group was 123 ± 16.25. 32.5 of the PD patients have EDS. The mean score for PDSS
tremor dominant PD patients was 92.46 where the mean score for rigidity dominant was 98.66.
The mean ESS score for tremor dominant PD patients was 6.77 and for those with rigidity
dominant the mean score was 6.39. There is no significant difference in PDSS mean score
between the stage 1 and 2 but if it compared to stages 3,4 and 5 there is significant difference.
Conclusions. PD patients have poorer sleep quality than matched age healthy control group.
Unlike medication type and anxiety there was significant correlation with the disease stage,
pain, depression and tremor dominant patients. There was a correlation with ESD and the
disease stage. | en_US |
dc.language.iso | en | en_US |
dc.publisher | MedEspera | en_US |
dc.subject | Parkinson's disease | en_US |
dc.subject | sleep disturbances | en_US |
dc.title | Sleep disturbances in Parkinson `s disease | en_US |
dc.type | Article | en_US |
Appears in Collections: | MedEspera 2020
|